NBTX logo

Nanobiotix S.A. (NBTX)

Profile

Full Name

Nanobiotix S.A.

Ticker

NASDAQ: NBTX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

France

IPO

December 11, 2020

Indexes

Not included

Website

https://www.nanobiotix.com

Employees

108

Key Details

Price

$9.74(+14.15%)

Market cap

$466.61M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-$12.56M(-138.64% YoY)

Annual EPS

-$1.56(-33.40% YoY)

PE ratio

-

Next earnings date

Sep 17, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $9.74
    NBTX price is $9.74

    30-Day Relative Volume

    3.13
    NBTX 30-day relative volume is 3.13

    Price Performance

    Price Most recent change

    +14.15%
    NBTX price was up +14.15% on Aug 21, 2025

    Price YTD change

    +239.27%
    NBTX price is up +239.27% since January 1st

    Price 1-year change

    +104.99%
    NBTX price is up +104.99% year-on-year

    Price 3-year change

    +119.55%
    NBTX price is up +119.55% over the past 3 years

    Price Range

    Price All-time high

    $21.55
    NBTX price is currently -54.82% below its historical high of $21.55

    Price 3-year low

    $1.75
    NBTX price is currently +456.40% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $466.61M
    NBTX market capitalization is $466.61 million

    Market cap 3-year change

    +201.67%
    NBTX market capitalization is up +201.67% over the past 3 years

    Market cap All-time high

    $677.37M
    NBTX market capitalization is currently -31.11% below its historical high of $677.37 million

    Market cap sector rank

    64.07%
    NBTX market capitalization is higher than 64.07% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +1.09%
    NBTX shares outstanding is up +1.09% year-on-year

    Shares Outstanding 3-Year Change

    +37.4%
    NBTX shares outstanding is up +37.4% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.64
    NBTX beta is 0.64

    200-day SMA

    $4.15
    NBTX price is currently +134.59% above its 200-day simple moving average

    50-day SMA

    $6.03
    NBTX price is currently +61.43% above its 50-day simple moving average

    RSI

    77.66
    NBTX 14-day relative strength index is 77.66

    Volume

    3.13
    NBTX 30-day relative volume is 3.13

    ATR

    $0.53
    NBTX average true range is $0.53

    10-day Historical Volatility

    94.99%
    NBTX 10-day historical volatility is 94.99%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    -$12.56M
    NBTX annual revenue is -$12.56 million

    Revenue Analysts estimate

    $15.11M
    NBTX annual revenue is currently -183.12% lower than the consensus analysts' forecast

    Revenue 1-year change

    -138.64%
    NBTX annual revenue is down -138.64% year-on-year

    Revenue Sector rank

    0.08%
    NBTX annual revenue is higher than 0.08% of companies in Healthcare sector

    EPS

    EPS

    -$1.56
    NBTX annual earnings per share is -$1.56

    EPS Analysts estimate

    -$0.69
    NBTX annual earnings per share is currently +124.89% higher than the consensus analysts' forecast

    EPS 1-year change

    -33.4%
    NBTX annual earnings per share is down -33.4% year-on-year

    EPS Sector rank

    41.78%
    NBTX annual earnings per share is higher than 41.78% of companies in Healthcare sector

    Profit

    Gross profit

    $0.00
    NBTX annual gross profit is $0.00

    Gross margin

    0.00%
    NBTX annual gross profit margin is 0.00%

    Operating profit

    -$78.61M
    NBTX annual operating income is -$78.61 million

    Operating margin

    -
    NBTX annual operating profit margin value is unknown

    Net income

    -$73.70M
    NBTX annual net profit is -$73.70 million

    Net margin

    -
    NBTX annual net profit margin value is unknown

    Expenses

    Total expenses

    $61.14M
    NBTX annual total expenses is $61.14 million

    Operating expenses

    $78.61M
    NBTX annual total operating expenses is $78.61 million

    Cost of goods sold

    -
    NBTX annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $0.00
    NBTX annual SGA is $0.00

    Depreciation and amortization

    $1.75M
    NBTX annual depreciation & amortization is $1.75 million

    Interest expense

    $0.00
    NBTX annual interest expense is $0.00

    Income tax

    -$3.46M
    NBTX annual income tax is -$3.46 million

    EBIT & EBITDA

    EBIT

    -$78.61M
    NBTX annual earnings before interest & taxes is -$78.61 million

    EBITDA

    -$76.86M
    NBTX annual EBITDA is -$76.86 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $69.81M
    NBTX annual total assets is $69.81 million

    Non current assets

    $6.16M
    NBTX annual long term assets is $6.16 million

    Current assets

    $63.65M
    NBTX annual total current assets is $63.65 million

    Cash and cash equivalents

    $51.50M
    NBTX annual cash & cash equivalents is $51.50 million

    Accounts receivable

    $3.08M
    NBTX annual accounts receivable is $3.08 million

    Inventory

    $0.00
    NBTX annual inventory is $0.00

    Liabilities

    Total liabilities

    $137.85M
    NBTX annual total liabilities is $137.85 million

    Long term liabilities

    $76.82M
    NBTX annual total long term liabilities is $76.82 million

    Current liabilities

    $61.03M
    NBTX annual total current liabilities is $61.03 million

    Accounts payable

    $4.64M
    NBTX annual accounts payable is $4.64 million

    Debt

    Total debt

    $52.71M
    NBTX annual total debt is $52.71 million

    Total debt 1-year change

    -5.64%
    NBTX annual total debt is down -5.64% year-on-year

    Long term debt

    $47.61M
    NBTX annual long term debt is $47.61 million

    Short term debt

    $5.10M
    NBTX annual short term debt is $5.10 million

    Equity & Capital

    Shareholders equity

    -$68.04M
    NBTX annual stockholders equity is -$68.04 million

    Book value

    -$68.04M
    NBTX annual book value is -$68.04 million

    Retained earnings

    $0.00
    NBTX annual retained earnings is $0.00

    Working capital

    $2.62M
    NBTX annual working capital is $2.62 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$22.21M
    NBTX annual cash flow from operations is -$22.21 million

    Cash from operations 1-year change

    -5.59%
    NBTX annual cash flow from operations is down -5.59% year-on-year

    Cash from investing

    -$1.03M
    NBTX annual cash flow from investing activities is -$1.03 million

    Cash from investing 1-year change

    -173.79%
    NBTX annual cash flow from investing activities is down -173.79% year-on-year

    Cash from financing

    -$4.49M
    NBTX annual cash flow from financing activities is -$4.49 million

    Cash from financing 1-year change

    -107.73%
    NBTX annual cash flow from financing activities is down -107.73% year-on-year

    CAPEX

    CAPEX

    $917.30K
    NBTX annual capital expenditures is $917.30 thousand

    CAPEX 1-year change

    +151.8%
    NBTX annual capital expenditures is up +151.8% year-on-year

    Free Cash Flow

    Free cash flow

    -$23.13M
    NBTX annual free cash flow is -$23.13 million

    Free cash flow 1-year change

    -8.08%
    NBTX annual free cash flow is down -8.08% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    0.00%
    NBTX annual gross profit margin is 0.00%

    Operating margin

    -
    NBTX annual operating profit margin value is unknown

    Net margin

    -
    NBTX annual net profit margin value is unknown

    ROA & ROE

    ROA

    -84.94%
    NBTX annual return on assets is -84.94%

    ROE

    108.32%
    NBTX annual return on equity is 108.32%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    NBTX price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    NBTX price to earnings ratio is unknown

    PB Ratio

    PB ratio

    -6.82
    NBTX price to book ratio is -6.82

    PB ratio Sector rank

    5.25%
    NBTX price to book ratio is higher than 5.25% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    NBTX price to sales ratio value is unknown

    PS ratio Sector rank

    -
    NBTX price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $467.82M
    NBTX enterprise value is $467.82 million

    Enterprise value Sector rank

    66.25%
    NBTX enterprise value is higher than 66.25% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -
    NBTX EV/EBITDA value is unknown

    EV/EBITDA Sector rank

    -
    NBTX EV/EBITDA is unknown

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    1.04
    NBTX annual current ratio is 1.04

    Quick ratio

    1.04
    NBTX annual quick ratio is 1.04

    Leverage

    Debt to equity

    -0.77
    NBTX annual debt to equity ratio is -0.77

    Interest coverage ratio

    -
    NBTX annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    NBTX piotroski f-score value is unknown

    Altman Z-Score

    -1.82
    NBTX altman z-score is -1.82

    Analyst ratings

    Recent major analysts updates

    Apr 4, 25 Guggenheim
    Buy
    Aug 28, 24 Guggenheim
    Buy
    Dec 8, 23 Leerink Partners
    Outperform
    Jan 6, 21 Evercore ISI Group
    Outperform

    Institutional Ownership

    Screeners with NBTX included

    Growing Shares Outstanding
    Best performing stocks last month
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Healthcare sector
    All stocks
    Best performing stocks last 3 years
    NASDAQ Listed Companies
    Stocks with high RSI
    Biggest stock gainers today
    • What is the ticker symbol for Nanobiotix S.A.?
    • Does Nanobiotix S.A. pay dividends?
    • What sector is Nanobiotix S.A. in?
    • What industry is Nanobiotix S.A. in?
    • What country is Nanobiotix S.A. based in?
    • When did Nanobiotix S.A. go public?
    • Is Nanobiotix S.A. in the S&P 500?
    • Is Nanobiotix S.A. in the NASDAQ 100?
    • Is Nanobiotix S.A. in the Dow Jones?
    • When was Nanobiotix S.A.'s last earnings report?
    • When does Nanobiotix S.A. report earnings?

    What is the ticker symbol for Nanobiotix S.A.?

    The ticker symbol for Nanobiotix S.A. is NASDAQ:NBTX

    Does Nanobiotix S.A. pay dividends?

    No, Nanobiotix S.A. does not pay dividends

    What sector is Nanobiotix S.A. in?

    Nanobiotix S.A. is in the Healthcare sector

    What industry is Nanobiotix S.A. in?

    Nanobiotix S.A. is in the Biotechnology industry

    What country is Nanobiotix S.A. based in?

    Nanobiotix S.A. is headquartered in France

    When did Nanobiotix S.A. go public?

    Nanobiotix S.A.'s initial public offering (IPO) was on December 11, 2020

    Is Nanobiotix S.A. in the S&P 500?

    No, Nanobiotix S.A. is not included in the S&P 500 index

    Is Nanobiotix S.A. in the NASDAQ 100?

    No, Nanobiotix S.A. is not included in the NASDAQ 100 index

    Is Nanobiotix S.A. in the Dow Jones?

    No, Nanobiotix S.A. is not included in the Dow Jones index

    When was Nanobiotix S.A.'s last earnings report?

    Nanobiotix S.A.'s most recent earnings report was on April 2, 2025

    When does Nanobiotix S.A. report earnings?

    The next expected earnings date for Nanobiotix S.A. is September 17, 2025
    On this page